Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Paeds Vivaspaediatric-dermatology

Paeds Vivas · paediatric-dermatology

Tinea and fungal skin infection — branching viva

Branching viva from a five-year-old with a scaly bald scalp patch and broken hair stubs, through the recognition of tinea capitis, the oral-therapy rule, the species-guided choice of terbinafine versus griseofulvin and household carrier screening, with a pivot to a four-year-old with a painful boggy kerion after contact with a kitten and a question on tinea incognito from a steroid-containing cream.

branching clinical structured oral
On this page & tools

Target exams

RACP General PaediatricsRACP DCEMRCPCH ClinicalRCPSC Pediatrics

Target exams

RACP General PaediatricsRACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
You are the paediatric registrar in the outpatient clinic. The examiner asks you to work through a five-year-old with an itchy scaly bald scalp patch and broken hair stubs, and later a four-year-old with a painful boggy purulent scalp mass after the family acquired a kitten, and a parent using a steroid-containing cream on an annular forearm rash. Information is released in stages.

Opening — framing the problem

The examiner begins: a five-year-old has a three-week history of an itchy, scaly bald patch on the scalp with broken hair stubs, black dots flush with the skin and an enlarged occipital node. Talk me through your approach. [1]

I would frame this as tinea capitis. The broken hair stubs and black dots are hair broken flush with the scalp surface, which is the endothrix pattern of Trichophyton tonsurans, and the enlarged occipital node favours a fungal scalp infection over a non-infectious dermatosis. I would confirm with potassium hydroxide microscopy of a plucked hair looking for branching septate hyphae and arthroconidia, and send fungal culture to identify the species. [1]

Branch A — the treatment principle

How would you treat this, and why? [2]

The principle is that tinea capitis always needs an oral antifungal, because the fungus lives inside the hair shaft and a topical cream cannot penetrate the follicle. So I would start an oral agent — griseofulvin or terbinafine, guided by the species — rather than a cream. A topical alone would fail, the hair loss would continue, and the child would keep shedding spores to siblings and classmates. [2]

Branch B — the species-guided drug choice

The culture returns Trichophyton tonsurans and the child weighs 22 kg. Which drug, what dose, and why not griseofulvin? [4]

I would choose terbinafine, because the meta-analyses show terbinafine is superior for Trichophyton species and griseofulvin is superior for Microsporum species. For a 22 kg child the terbinafine dose is 125 mg daily, using the weight bands of 62.5 mg daily under 20 kg, 125 mg daily for 20 to 40 kg, and 250 mg daily over 40 kg, given for 4 weeks. Griseofulvin would be the better choice if the organism were Microsporum, but for Trichophyton tonsurans terbinafine gives a shorter, more effective course. [4] [5]

Branch C — preventing recurrence

After the course the scalp clears, but three weeks later it returns. What did you miss? [10]

I missed the household reservoir. Recurrence after an adequate oral course almost always reflects untreated asymptomatic scalp carriage in family contacts and an untreated pet. I would screen and treat the household contacts, use an antifungal shampoo such as ketoconazole to reduce spore shedding, and have a veterinarian examine and treat any pets. For a zoophilic organism I would specifically ask about kittens and puppies as the source. [10]

Branch D — the pivot to kerion

Now a four-year-old presents with a painful, boggy, purulent, inflamed scalp mass with crusting and enlarged nodes, two weeks after the family acquired a kitten. What is this and how do you manage it? [1]

This is a kerion, an intense delayed hypersensitivity reaction to a zoophilic dermatophyte, most likely Microsporum canis from the kitten. I would start an oral antifungal immediately and add a short tapering course of oral corticosteroid to quiet the inflammation and reduce the risk of permanent scarring alopecia. I would explicitly avoid incision and drainage, because the pus is inflammatory rather than a drainable bacterial abscess. I would add an antistaphylococcal antibiotic only if there were genuine signs of secondary bacterial infection. [1] [2]

Closing — the steroid cream

A parent asks whether to keep using a combined corticosteroid, antifungal and antibiotic cream on an itchy annular forearm rash. What do you advise? [6]

I would advise stopping it. A topical corticosteroid applied to an undiagnosed tinea lesion produces tinea incognito: it suppresses the inflammatory border and the itch, so the child feels better, but the fungus is unopposed and spreads, the classic ring is lost, and the lesion becomes atrophic and pustular. I would stop the cream, confirm tinea with potassium hydroxide microscopy of the active border, and treat with a plain topical antifungal such as terbinafine or clotrimazole, reserving oral therapy for extensive disease. The rule is never to use a steroid-containing cream on an unrecognised scaly annular lesion. [6]

References

  1. [1]Gupta AK, Polla Ravi S, Wang T, et al. An update on tinea capitis in children. Pediatr Dermatol, 2024.PMID 39113245
  2. [2]Fuller LC, Barton RC, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of tinea capitis 2014. Br J Dermatol, 2014.PMID 25234064
  3. [4]Tey HL, Tan AS, Chan YC Meta-analysis of randomized, controlled trials comparing griseofulvin and terbinafine in the treatment of tinea capitis. J Am Acad Dermatol, 2011.PMID 21334096
  4. [5]Gupta AK, Drummond-Main C Meta-analysis of randomized, controlled trials comparing particular doses of griseofulvin and terbinafine for the treatment of tinea capitis. Pediatr Dermatol, 2013.PMID 22994156
  5. [6]Leung AK, Lam JM, Leong KF, et al. Tinea corporis: an updated review. Drugs Context, 2020.PMID 32742295
  6. [10]Dessinioti C, Papadogeorgaki E, Athanasopoulou V, et al. Screening for asymptomatic scalp carriage in household contacts of patients with tinea capitis during 1997-2011: a retrospective hospital-based study. Mycoses, 2014.PMID 24372570